NCT04377555 · Interventional trial
Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab
Overall registry status Completed
Phase 4
Conditions Multiple Sclerosis, Relapsing
Delaware Valley sites
- Jefferson University Hospitals, Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory